Atopic Dermatitis
Latest News
CHMP recommends marketing of biologic for atopic dermatitis
Most adverse events across the three pivotal studies were mild or moderate.
Latest News
Company submits supplemental NDA for topical atopic dermatitis treatment
The development is based on results from two identical phase 3, vehicle-controlled trials.
Latest News
Consider housing insecurity, other issues when managing challenging skin diseases in children, expert says
In children with skin diseases, particularly complex disorders like hidradenitis suppurativa, conversations about adequate housing and other...
Latest News
Free teledermatology clinic helps underserved patients initiate AD care
The program "is meant to be a stepping point for initiating care ... to set someone up for success for recurrent telehealth visits in the future...
Latest News
When treating AD in children, experts consider adherence, other aspects of treatment
One way to avoid moving to the most expensive drugs quickly is simply verifying that patients were compliant with the drugs that were used first,...
Latest News
Ocular complications of dermatologic treatments: Advice from a pediatric ophthalmologist
There are several potential mechanisms by which biologics targeting IL-13 might increase risk of ocular complications, one of which is the role...
Feature
Camp Discovery: A place for children to be comfortable in their own skin
Chronic skin conditions carry a heavy psychological burden, but a special 1-week camp for youth 8-16 founded 30 years ago aims to lift that weight...
Latest News
New guidelines for MTX use in pediatric inflammatory skin disease unveiled
One of the recommendations states that liver biopsy is not indicated for routine monitoring of pediatric patients taking low-dose MTX.
Latest News
Dupilumab outcomes stable at end of open label atopic dermatitis study
Other recent research on the biologic has shown that it improves lesional skin barrier function and rapidly reduces the abundance of ...
Latest News
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
For abrocitinib, "we're starting to get good numbers of [adolescents] who've had about 2 years of exposure," Dr. Lawrence Eichenfield said.
Latest News
Can online mindfulness and self-compassion training improve quality of life for patients with atopic dermatitis?
"Stress can make the skin worse, but at the same time the skin disease and symptoms cause stress," Dr. Peter A. Lio said.